Bayer
Tracked across 21 events · 309 articles · First seen Oct 06, 2025 · Last active Jul 06, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Bayer Group is consolidating its U.S. glyphosate business into Ruveon LLC to optimize operations and enhance focus on innovation and profitability within its Crop Science division.
Jul 01, 2026 · 6 articles
Business
Impact: Bayer has agreed to a proposed $7.25 billion settlement to resolve thousands of lawsuits alleging its Roundup weedkiller causes cancer, aiming to reduce litigation uncertainty and financial strain. This settlement is crucial for Bayer's financial survival and ability to continue selling Roundup in agricultural markets.
Feb 17, 2026 · 10 articles
Regulatory
Impact: Bayer, the owner of Bayer — Monsanto, received a significant legal victory as the Supreme Court ruling shields it from thousands of 'failure-to-warn' lawsuits regarding Roundup, positively impacting its stock price and reducing potential liabilities. This decision provides regulatory clarity for the company and the agricultural industry.
Jun 25, 2026 · 127 articles
Business
Impact: Bayer is partnering with Natur-Tec India Private Limited to jointly develop biodegradable and compostable seedling cups, contributing its crop science capabilities to advance sustainable agriculture.
Jun 16, 2026 · 7 articles
Regulatory
Impact: Bayer, as the owner of Bayer — Monsanto, faces continued scrutiny and legal challenges regarding the safety of Roundup and glyphosate, impacting its reputation and potentially its financial standing due to ongoing litigation and regulatory pressure.
Jul 06, 2026 · 6 articles
Business
Impact: Bayer invested in Bicara Therapeutics' $180 million financing, supporting the development of deupirfenidone.
Jul 02, 2026 · 6 articles
Tech
Impact: Bayer's subsidiary, MiNK Therapeutics, is exploring approaches related to regulatory T cells, showing the company's involvement in this emerging field.
Oct 06, 2025 · 6 articles
Regulatory
Impact: Bayer is reviewing its options regarding the United States — Medicaid pilot program, having missed the application deadline.
Apr 20, 2026 · 6 articles
100
Bayer announced MOU Natur-Tec India Private LimitedNatur-Tec, Bayer Develop...
100
Bayer consolidated business RuveonBayer Consolidates US...
100
Natur-Tec India Private Limited announced MOU BayerNatur-Tec, Bayer Develop...
85
Bayer surgedSupreme Court Shields...
81
John Durnell filed lawsuit BayerSupreme Court Shields...
80
Bayer began pilot trialsNatur-Tec, Bayer Develop...
80
Guyana — Guyana Environmental Protection Agency approved label BayerSupreme Court Shields...
79
Bayer set asideSupreme Court Shields...
79
United States — Supreme Court of the United States agreed to hear appeal BayerSupreme Court Shields...
70
Bayer welcomed decisionSupreme Court Shields...
60
Bayer participated in financing Bicara TherapeuticsCelea Therapeutics Secures...
60
Bayer persuaded states to pass lawsSupreme Court Shields...
50
Bayer rejected characterisationGlyphosate Review...
45
Bayer acquired Bayer — MonsantoSupreme Court Shields...
41
Bayer removed glyphosateSupreme Court Shields...
12
Donald Trump sided with BayerSupreme Court Shields...
ERGEN INTELLIGENCE
Track Bayer live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard